1-3 of 3
Anna R Franklin, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Antibody-Drug Conjugate Brentuximab Vedotin (SGN-35) Induced Multiple Objective Responses in Patients with Relapsed or Refractory CD30-Positive Lymphomas in a Phase 1 Weekly Dosing Study.

Michelle Fanale, MD, Nancy L Bartlett, MD, Andres Forero-Torres, MD, Joseph Rosenblatt, MD, Sandra J Horning, MD, Anna R Franklin, MD, Carmel M Lynch, PhD, Eric L Sievers, MD, Dana A Kennedy, PharmD, BCOP
Journal: Blood
Blood (2009) 114 (22): 2731.
https://doi.org/10.1182/blood.V114.22.2731.2731
Published: 2009
Journal Articles

A Therapeutic Approach for Acute Leukemias: Glycolysis Inhibition Revisited

Lauren J. Akers, DO, Alejandro G. Levy, MD, Anna R. Franklin, MD, Wendy Fang, MD, Peng Huang, PhD, Patrick Zweidler-McKay, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 5020.
https://doi.org/10.1182/blood.V112.11.5020.5020
Published: 2008
Journal Articles

The Novel Glycolysis Inhibitor, 3-BrOP, Has Broad Activity Against Acute Lymphoblastic Leukemias and Potentiates Methotrexate and Rapamycin.

Lauren J. Akers, DO, Anna R. Franklin, MD, Peng Huang, MD, PhD, Patrick A. Zweidler-McKay, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 4203.
https://doi.org/10.1182/blood.V110.11.4203.4203
Published: 2007